{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:58:28Z","timestamp":1787313508682,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473313"],"award-info":[{"award-number":["81473313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Public Service Industry","award":["201407002"],"award-info":[{"award-number":["201407002"]}]},{"name":"National Public Health Industry","award":["2014002"],"award-info":[{"award-number":["2014002"]}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province","doi-asserted-by":"publisher","award":["KYLX 0969"],"award-info":[{"award-number":["KYLX 0969"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.intimp.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T12:45:14Z","timestamp":1494333914000},"page":"102-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-\u03baB and JAK\/STAT signaling pathways in rats"],"prefix":"10.1016","volume":"48","author":[{"given":"Lingling","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2017.05.002_bb0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1074248415591698","article-title":"Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis","volume":"21","author":"Watson","year":"2016","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2017.05.002_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2013-000004","article-title":"Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function","volume":"1","author":"Medenwald","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.intimp.2017.05.002_bb0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jcmm.12709","article-title":"Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress","volume":"20","author":"Zhang","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2017.05.002_bb0020","first-page":"3217","article-title":"Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK\/STAT pathway","volume":"9","author":"Al-Rasheed","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2017.05.002_bb0025","first-page":"227","article-title":"Gambogic acid suppresses pressure overload cardiac hypertrophy in rats","volume":"3","author":"Liu","year":"2013","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"10.1016\/j.intimp.2017.05.002_bb0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbrc.2014.04.112","article-title":"The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice","volume":"448","author":"Qiao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2017.05.002_bb0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/emmm.201200240","article-title":"Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production","volume":"4","author":"Wu","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2017.05.002_bb0040","first-page":"355","article-title":"N-acetyl cysteine inhibits endothelin-1-induced ROS dependent cardiac hypertrophy through superoxide dismutase regulation","volume":"17","author":"Mushtaq","year":"2015","journal-title":"Cell J."},{"key":"10.1016\/j.intimp.2017.05.002_bb0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0735-1097(00)01123-2","article-title":"Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte","volume":"37","author":"Tanaka","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.06.002","article-title":"Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload","volume":"287","author":"Guo","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0055","first-page":"2357","article-title":"Effection of myocardial cell\/collagen compound on ventricular electrophysiology in rats with myocardial infarction","volume":"20","author":"Ruping","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2017.05.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166845","article-title":"Atorvastatin improves ventricular remodeling after myocardial infarction by interfering with collagen metabolism","volume":"11","author":"Reichert","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2017.05.002_bb0065","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.3892\/etm.2015.2816","article-title":"Naringenin attenuates pressure overload-induced cardiac hypertrophy","volume":"10","author":"Zhang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2017.05.002_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FJC.0000000000000410","article-title":"Inhibition of TNF-alpha-mediated NF-kappaB activation by ginsenoside Rg1 contributes the attenuation of cardiac hypertrophy induced by abdominal aorta coarctation","volume":"68","author":"Tang","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0075","article-title":"Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-kappaB\/PGC-1alpha signaling mediated energy biosynthesis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2017.05.002_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jep.2016.03.015","article-title":"Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-kappaB pathway","volume":"186","author":"Mao","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.taap.2015.02.023","article-title":"Inhibition of NF-kappaB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress","volume":"284","author":"Yu","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0090","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.lfs.2008.02.012","article-title":"Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK\/STAT pathway","volume":"82","author":"Liu","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2017.05.002_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCRESAHA.107.164699","article-title":"Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice","volume":"102","author":"Boengler","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2017.05.002_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.taap.2013.11.011","article-title":"Isoproterenol effects evaluated in heart slices of human and rat in comparison to rat heart in vivo","volume":"274","author":"Herrmann","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","article-title":"Proinflammatory cytokines in heart failure: double-edged swords","volume":"15","author":"Hedayat","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.intimp.2017.05.002_bb0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/1472-6882-14-474","article-title":"Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2017.05.002_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2012.09.016","article-title":"Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-beta receptor-mediated ERK and p38 pathways","volume":"265","author":"Zhang","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0120","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.4238\/2014.October.20.7","article-title":"Intermedin protects against myocardial ischemia-reperfusion injury in hyperlipidemia rats","volume":"13","author":"Yang","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.intimp.2017.05.002_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.diabres.2015.04.022","article-title":"The relationship between the oxidative stress and the cardiac hypertrophy in infants of diabetic mothers","volume":"109","author":"Topcuoglu","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.intimp.2017.05.002_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11010-007-9459-9","article-title":"Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine","volume":"303","author":"Araujo","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2017.05.002_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cbi.2009.05.007","article-title":"Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark","volume":"181","author":"Singh","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2017.05.002_bb0140","doi-asserted-by":"crossref","first-page":"36251","DOI":"10.1038\/srep36251","article-title":"Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-kappaB pathway","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2017.05.002_bb0145","first-page":"940","article-title":"Effect of Leonurus stachydrine on myocardial cell hypertrophy","volume":"35","author":"Guo","year":"2012","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.intimp.2017.05.002_bb0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2017.05.002_bb0155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.RES.68.3.856","article-title":"Cellular basis of chronic ventricular remodeling after myocardial infarction in rats","volume":"68","author":"Olivetti","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2017.05.002_bb0160","doi-asserted-by":"crossref","first-page":"35383","DOI":"10.18632\/oncotarget.6168","article-title":"Moderate exercise training attenuates aging-induced cardiac inflammation, hypertrophy and fibrosis injuries of rat hearts","volume":"6","author":"Liao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2017.05.002_bb0165","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1039764","article-title":"Restoring inflammatory balance as a potential preventive strategy for inflammation induced cancer","volume":"4","author":"Hefetz-Sela","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2017.05.002_bb0170","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cmet.2014.05.009","article-title":"IL-6 strikes a balance in metabolic inflammation","volume":"19","author":"Covarrubias","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2017.05.002_bb0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1113\/expphysiol.2005.032615","article-title":"Trimetazidine improved Ca2+ handling in isoprenaline-mediated myocardial injury of rats","volume":"91","author":"Meng","year":"2006","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI200316326","article-title":"Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+\/calmodulin kinase II","volume":"111","author":"Zhu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2017.05.002_bb0185","doi-asserted-by":"crossref","first-page":"H211","DOI":"10.1152\/ajpheart.00581.2007","article-title":"Effects of isoproterenol treatment for 7days on inflammatory mediators in the rat aorta","volume":"295","author":"Davel","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjp.0706749","article-title":"Changes in vascular reactivity following administration of isoproterenol for 1week: a role for endothelial modulation","volume":"148","author":"Davel","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4614-6093-0_21","article-title":"Effects of taurine on myocardial cGMP\/cAMP ratio, antioxidant ability, and ultrastructure in cardiac hypertrophy rats induced by isoproterenol","volume":"776","author":"Yang","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0200","first-page":"4869","article-title":"High fructose causes cardiac hypertrophy via mitochondrial signaling pathway","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2017.05.002_bb0205","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejphar.2010.09.018","article-title":"Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-kappaB signaling","volume":"649","author":"Xiong","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2017.05.002_bb0210","first-page":"894","article-title":"Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy: potential role of HSF1 and NF-kappaB p65 signaling","volume":"43","author":"Xu","year":"2015","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.intimp.2017.05.002_bb0215","article-title":"Capsazepine inhibits JAK\/STAT3 signaling, tumor growth, and cell survival in prostate cancer","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2017.05.002_bb0220","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.18632\/oncotarget.7272","article-title":"HIF-3alpha1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2017.05.002_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxlet.2016.11.006","article-title":"The ROS-mediated activation of STAT-3\/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells","volume":"264","author":"Zhu","year":"2016","journal-title":"Toxicol. Lett."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691730173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691730173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T22:10:17Z","timestamp":1569276617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691730173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":45,"alternative-id":["S156757691730173X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.05.002","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-\u03baB and JAK\/STAT signaling pathways in rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}